PDCD1 and melanoma: Furthermore, MDSC inhibition by phenformin, an antidiabetic drug from the biguanide class, was able to enhance the effect of PD-1 blockade reflected by an increased CD8+ T cell infiltration in the BRAF V600E/PTEN-null melanoma mouse model (90).